Hubei Biocause Pharmaceutical (000627.SZ) Dividend: History, Dates & Yield - 2025
Tags:Dividend History
Hubei Biocause Pharmaceutical announced a annually dividend of ¥0.11 per ordinary share, payable on 2023-05-30, with an ex-dividend date of 2023-05-30. Hubei Biocause Pharmaceutical typically pays dividends one times a year.
Find details on Hubei Biocause Pharmaceutical's dividend performance with a comprehensive history of past and upcoming payments.
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2023-05-30 | ¥0.11 | annually | 2023-05-30 |
| 2022-06-02 | ¥0.01 | annually | 2022-06-02 |
| 2021-06-04 | ¥0.01 | annually | 2021-06-04 |
| 2020-05-20 | ¥0.10 | annually | 2020-05-20 |
| 2019-09-26 | ¥0.03 | annually | 2019-09-26 |
| 2018-10-12 | ¥0.03 | annually | 2018-10-12 |
| 2018-06-08 | ¥0.01 | annually | 2018-06-08 |
| 2017-06-21 | ¥0.03 | annually | 2017-06-21 |
| 2016-04-14 | ¥0.01 | annually | |
| 2010-04-12 | ¥0.02 | annually |
Dividend Increase
Hubei Biocause Pharmaceutical's dividend growth over the last five years (2019-2023) was 433.67% per year, while over the last ten years (2014-2023), it was 242.55% per year. In comparison, Changjiang Securities has seen an average growth rate of 138.00% over the past five years and Jilin Aodong Pharmaceutical's growth rate was 43.33%.
By comparing Hubei Biocause Pharmaceutical's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Hubei Biocause Pharmaceutical's current trailing twelve-month (TTM) dividend yield is nan%. Over the last 12 months, Hubei Biocause Pharmaceutical has maintained this yield, but how does it compare to similar stocks? For example, Changjiang Securities offers a yield of 1.85%, while Jilin Aodong Pharmaceutical provides a yield of 4.82%. Comparing similar stocks can help investors assess Hubei Biocause Pharmaceutical's yield and make more informed decisions.
| Company | Dividend Yield | Annual Dividend | Stock Price |
|---|---|---|---|
| Hubei Biocause Pharmaceutical (000627.SZ) | NaN% | ¥0.11 | ¥3.95 |
| Changjiang Securities (000783.SZ) | 1.85% | ¥0.12 | ¥6.66 |
| Jilin Aodong Pharmaceutical (000623.SZ) | 4.82% | ¥0.8 | ¥16.79 |
Dividend Yield Calculator
Interested in purchasing Hubei Biocause Pharmaceutical stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Hubei Biocause Pharmaceutical has a payout ratio of -1.77%. In comparison, Changjiang Securities has a payout ratio of 1.49%, while Jilin Aodong Pharmaceutical's payout ratio is 0.81%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Hubei Biocause Pharmaceutical
Frequently Asked Question
How much is the next Hubei Biocause Pharmaceutical dividend?
Hubei Biocause Pharmaceutical's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Hubei Biocause Pharmaceutical dividend. The next Hubei Biocause Pharmaceutical dividend will be released in June.
When is Hubei Biocause Pharmaceutical dividend paid?
Hubei Biocause Pharmaceutical pays dividends on a annually basis. The specific dates may vary each year but are generally around June. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Hubei Biocause Pharmaceutical pay?
The specific amount of Hubei Biocause Pharmaceutical dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Hubei Biocause Pharmaceutical's dividend history.
Does Hubei Biocause Pharmaceutical stock pay dividends?
Yes, Hubei Biocause Pharmaceutical does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Hubei Biocause Pharmaceutical's dividend history.
How much dividend does Hubei Biocause Pharmaceutical pay?
Hubei Biocause Pharmaceutical paid ¥0.0 in 2025, ¥0.0 in 2024, ¥0.11 in 2023, ¥0.005 in 2022, ¥0.01 in 2021, and ¥0.1 in 2020.
How often does Hubei Biocause Pharmaceutical pay dividends?
Hubei Biocause Pharmaceutical typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around June.
What is Hubei Biocause Pharmaceutical's dividend yield?
The current dividend yield for Hubei Biocause Pharmaceutical is -%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Hubei Biocause Pharmaceutical's exact dividend yield.
When does Hubei Biocause Pharmaceutical go ex dividend?
Hubei Biocause Pharmaceutical's ex-dividend date for the latest dividend was on 2023-05-30. Hubei Biocause Pharmaceutical typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Hubei Biocause Pharmaceutical dividend paid?
Hubei Biocause Pharmaceutical pays dividends on a annually basis, typically around June, but the exact dates can vary each year.
Will Hubei Biocause Pharmaceutical increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Hubei Biocause Pharmaceutical will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Hubei Biocause Pharmaceutical dividend per share?
Hubei Biocause Pharmaceutical paid ¥0.0 per share in 2025 and ¥0.0 per share in 2024. The amount of dividend per share that Hubei Biocause Pharmaceutical pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Hubei Biocause Pharmaceutical a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Hubei Biocause Pharmaceutical a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Hubei Biocause Pharmaceutical a dividend stock?
Yes, Hubei Biocause Pharmaceutical is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Hubei Biocause Pharmaceutical a good dividend stock?
Whether Hubei Biocause Pharmaceutical is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Hubei Biocause Pharmaceutical has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Hubei Biocause Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating Hubei Biocause Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Hubei Biocause Pharmaceutical pay dividends monthly?
Hubei Biocause Pharmaceutical typically pays dividends on a annually basis.
Does Hubei Biocause Pharmaceutical pay dividends quarterly?
Hubei Biocause Pharmaceutical currently pays dividends on a annually basis.
Has Hubei Biocause Pharmaceutical ever paid a dividend?
Yes, Hubei Biocause Pharmaceutical has a history of paying dividends to its shareholders. Hubei Biocause Pharmaceutical is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Hubei Biocause Pharmaceutical dividend stocks?
To buy Hubei Biocause Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Hubei Biocause Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Hubei Biocause Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Hubei Biocause Pharmaceutical pay dividends 2024?
Hubei Biocause Pharmaceutical pays dividends on a annually basis. 2024 dividend payments are in 2023-05-30. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Hubei Biocause Pharmaceutical increase its dividend in 2024?
Decisions regarding Hubei Biocause Pharmaceutical dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Hubei Biocause Pharmaceutical dividend overview you can look into the above table of dividend history.
How Hubei Biocause Pharmaceutical dividend works?
The Hubei Biocause Pharmaceutical dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Hubei Biocause Pharmaceutical's dividend process works:
1. Determination of Dividend: Hubei Biocause Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Hubei Biocause Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Hubei Biocause Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Hubei Biocause Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: Hubei Biocause Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Hubei Biocause Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Hubei Biocause Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Hubei Biocause Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Hubei Biocause Pharmaceutical dividends paid?
Hubei Biocause Pharmaceutical dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Hubei Biocause Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Hubei Biocause Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Hubei Biocause Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: Hubei Biocause Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Hubei Biocause Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Hubei Biocause Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Hubei Biocause Pharmaceutical pay dividends?
Hubei Biocause Pharmaceutical typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Hubei Biocause Pharmaceutical pay dividends?
The general pattern is that Hubei Biocause Pharmaceutical pays dividends around June. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Hubei Biocause Pharmaceutical dividend safe?
The safety of Hubei Biocause Pharmaceutical's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Hubei Biocause Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Hubei Biocause Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of Hubei Biocause Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Hubei Biocause Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.